Folgen
Drakeley C
Titel
Zitiert von
Zitiert von
Jahr
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …
S Rts
Lancet 386 (9988), 31-45, 2015
2160*2015
Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination
T Bousema, C Drakeley
Clinical microbiology reviews 24 (2), 377-410, 2011
8922011
Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study
H Reyburn, R Mbatia, C Drakeley, I Carneiro, E Mwakasungula, ...
Bmj 329 (7476), 1212, 2004
8372004
Increased proportions of outdoor feeding among residual malaria vector populations following increased use of insecticide-treated nets in rural Tanzania
TL Russell, NJ Govella, S Azizi, CJ Drakeley, SP Kachur, GF Killeen
Malaria journal 10 (1), 1-10, 2011
7422011
Asymptomatic malaria infections: detectability, transmissibility and public health relevance
T Bousema, L Okell, I Felger, C Drakeley
Nature Reviews Microbiology 12 (12), 833-840, 2014
7272014
Factors determining the occurrence of submicroscopic malaria infections and their relevance for control
LC Okell, T Bousema, JT Griffin, AL Ouédraogo, AC Ghani, CJ Drakeley
Nature communications 3 (1), 1237, 2012
6802012
Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies
JT Griffin, TD Hollingsworth, LC Okell, TS Churcher, M White, W Hinsley, ...
PLoS medicine 7 (8), e1000324, 2010
6332010
Submicroscopic Infection in Plasmodium falciparum-Endemic Populations: A Systematic Review and Meta-Analysis
LC Okell, AC Ghani, E Lyons, CJ Drakeley
The Journal of infectious diseases 200 (10), 1509-1517, 2009
6262009
Hitting hotspots: spatial targeting of malaria for control and elimination
T Bousema, JT Griffin, RW Sauerwein, DL Smith, TS Churcher, W Takken, ...
PLoS medicine 9 (1), e1001165, 2012
6252012
Estimating medium-and long-term trends in malaria transmission by using serological markers of malaria exposure
CJ Drakeley, PH Corran, PG Coleman, JE Tongren, SLR McDonald, ...
Proceedings of the National Academy of Sciences 102 (14), 5108-5113, 2005
5652005
Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial
H Reyburn, H Mbakilwa, R Mwangi, O Mwerinde, R Olomi, C Drakeley, ...
Bmj 334 (7590), 403, 2007
5492007
Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age
P Bejon, J Lusingu, A Olotu, A Leach, M Lievens, J Vekemans, S Mshamu, ...
New England Journal of Medicine 359 (24), 2521-2532, 2008
5242008
Genome-wide and fine-resolution association analysis of malaria in West Africa
M Jallow, YY Teo, KS Small, KA Rockett, P Deloukas, TG Clark, K Kivinen, ...
Nature genetics 41 (6), 657-665, 2009
4532009
Operational strategies to achieve and maintain malaria elimination
B Moonen, JM Cohen, RW Snow, L Slutsker, C Drakeley, DL Smith, ...
The Lancet 376 (9752), 1592-1603, 2010
4462010
Antifolate antimalarial resistance in southeast Africa: a population-based analysis
C Roper, R Pearce, B Bredenkamp, J Gumede, C Drakeley, F Mosha, ...
The Lancet 361 (9364), 1174-1181, 2003
3872003
Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria
H Reyburn, R Mbatia, C Drakeley, J Bruce, I Carneiro, R Olomi, J Cox, ...
Jama 293 (12), 1461-1470, 2005
3662005
Identification of hot spots of malaria transmission for targeted malaria control
T Bousema, C Drakeley, S Gesase, R Hashim, S Magesa, F Mosha, ...
The Journal of infectious diseases 201 (11), 1764-1774, 2010
3632010
A research agenda for malaria eradication: vector control
malERA Consultative Group on Vector Control
PLoS medicine 8 (1), e1000401, 2011
359*2011
Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites
RTS, S Clinical Trials Partnership (2014)
PLoS medicine 11 (7), e1001685, 2014
3332014
Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
MT White, R Verity, JT Griffin, KP Asante, S Owusu-Agyei, B Greenwood, ...
The Lancet infectious diseases 15 (12), 1450-1458, 2015
3322015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20